NCT03754413View on ClinicalTrials.gov

Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face

NACompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

March 9, 2020

Study Completion Date

March 9, 2020

Conditions
Mid Face Volume Loss
Interventions
DEVICE

experimental

Neuramis® Deep Lidocaine

DRUG

comparator

No-treatment

Trial Locations (1)

Unknown

Beijing Hopsital, Beijing

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT03754413 - Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face | Biotech Hunter | Biotech Hunter